| [Antiapoptotic oncogene bcl-2 induces a program of senescence in E1A + c-Ha-ras-transformants treated with adriamycin]. | None |
| Prevention of apoptosis in CNTF-dependent neurons by a mutant ICE and by viral protein CrmA but not by proto-oncogene product Bcl-2. | None |
| overexpression of Bcl-2 may result in oncogene addiction of the cancer cell | None |
| Results suggest that lin-35 promotes germ cell apoptosis by repressing the expression of ced-9, an anti-apoptotic C. elegans gene that is orthologous to the human proto-oncogene BCL2. | None |
| Spectroscopy probing of the formation, recognition, and conversion of a G-quadruplex in the promoter region of the bcl-2 oncogene. | None |
| The eukaryotic translation initiation factor 2-alpha kinase 2 mediates the regulation of the protein level and the phosphorylation status of Proto-Oncogene Proteins c-bcl-2, providing a novel mechanism of palmitate-induced apoptosis in HepG2 cells. | None |
| Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2. | None |
| Investigation of the formation and recognition of a dimeric G-quadruplex in the promoter of Bcl-2 proto-oncogene by electrospray ionization mass spectrometry. | None |
| The anti-autophagic property of Bcl-2 is a key feature of Bcl-2-mediated oncogenesis. | None |
| The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors. | None |
| Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2. | None |
| bcl-2 proto-oncogene, apoptosis and oncogenesis. | None |
| Bcl-2 oncogene blocks differentiation and extends viability but does not immortalize normal human keratinocytes. | None |
| Functional similarity between adenovirus e1b 19k gene and bcl2 oncogene - mutant complementation and suppression of cell-death induced by DNA-damaging agents. | None |
| Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. | None |
| Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. | None |
| Epigenetic silencing of Bcl-2, CEBPA and p14(ARF) by the AML1-ETO oncoprotein contributing to growth arrest and differentiation block in the U937 cell line. | None |
| Oligonucleotide suppression of bcl-2 in LNCaP cells is compensated by increased androgen sensitivity, p53 and oncogene activity, and suppressed caspase-3. | None |
| Immunolocalization of Bcl-2 oncoprotein in amlodipine-induced gingival overgrowth. | None |
| Oncogene PKCepsilon controls INrf2-Nrf2 interaction in normal and cancer cells through phosphorylation of INrf2. | None |